Rapid

Archives of Pathology and Laboratory Medicine

Volumn 137, Issue 6, 2013, Pages 812-819

  Wilson, Michael L ^a,b  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AIDS RELATED COMPLEX; ANTIBIOTIC RESISTANCE; CHILD; COMORBIDITY; DRUG EFFECT; FEMALE; GENETICS; HEALTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; META ANALYSIS (TOPIC); MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PRESCHOOL CHILD; REVIEW; TIME; TUBERCULOSIS; WOMEN'S HEALTH;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; COINFECTION; COMORBIDITY; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; HIV; HUMANS; INFANT; ISONIAZID; META-ANALYSIS AS TOPIC; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TIME FACTORS; TUBERCULOSIS; WOMEN'S HEALTH; WORLD HEALTH;

MLCS; MLOWN;

EID: 84879677734     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0578-RA     Document Type: Article

References (65)

1. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing: WHO Report 2010. Geneva, Switzerland: WHO Press; 2011.
2. Caviedes L, Lee T-S, Gilman RH, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J Clin Microbiol. 2000;38:1203-1208. (Pubitemid 30140586)
3. Moore DAJ, Mendoza D, Gilman RH, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol. 2004;42:4432-4437. (Pubitemid 39362351)
4. Moore DAJ, Evans CAW, Gilman RH, et al. Microscopic-observation drugsusceptibility assay for the diagnosis of tuberculosis. N Engl J Med. 2006;355:1539-1550. (Pubitemid 44547806)
5. Mello FCQ, Arias MS, Rosales S, et al. Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol. 2007;45:3387-3389. (Pubitemid 47585667)
6. Ha DTM, Lan NTN, Kiet VS, et al. Diagnosis of pulmonary tuberculosis in HIV-positive patients by microscopic observation drug susceptibility assay. J Clin Microbiol. 2010;48:4573-4579.
7. Minion J, Leung E, Menzies D, Pai M. Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2010; 10:688-698.
8. World Health Organization. Fluorescent light emitting diode (LED) microscopy for diagnosis of tuberculosis: policy statement. http://www.who.int/ tb/laboratory/who-policy-led-microscopy-july10.pdf. July 2010. Accessed November, 2011.
9. Martin A, Paasch F, Von Groll A, et al. Thin-layer agar for detection of resistance to rifampicin, ofloxacin and kanamycin in Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis. 2009;13:1301-1304.
10. Robledo J, Mejia GI, Paniagua L, Martin A, Guzmán A. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method. Int J Tuberc Lung Dis 2008;12:1482-1484.
11. Schaberg T, Reichert B, Schu lin T, Lode H, Mauch H. Rapid drug susceptibility testing of Mycobacterium tuberculosis using conventional solid media. Eur Resp J. 1995;8:1688-1693.
12. Mshana RN, Tadesse G, Abate G, Miorner H. Use of 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampicinresistant Mycobacterium tuberculosis. J Clin Microbiol. 1998;36:1214-1219. (Pubitemid 28208001)
13. Abate G, Mashana RN, Miorner H. Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 1998;2:1011-1016. (Pubitemid 29005219)
14. Foongladda S, Roengsanthia D, Arjrattanakool W, Chuchottaworn C, Chaiprasert A, Franzblau SG. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2002;6:1118-1122. (Pubitemid 36054968)
15. Martin A, Morcillo N, Lemus D, et al. Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. Int J Tuberc Lung Dis. 2005;9:901-906. (Pubitemid 41139650)
16. Abate G, Aseffa A, Selassie A, et al. Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2004;42:871-873. (Pubitemid 38222685)
17. Montoro E, Lemus D, Echemendia M, Martin A, Portaels F, Palomino JC. Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother. 2005; 55:500-505. (Pubitemid 40542590)
18. Muzaffar R, Batool S, Aziz F, Naqvi A, Rizvi A. Evaluation of the FASTPlaqueTB assay for direct detection of Mycobacterium tuberculosis in sputum specimens. Int J Tuberc Lung Dis. 2002;6:635-640. (Pubitemid 36898190)
19. Albert H, Trollip A, Seaman T, Mole RJ. Simple, phage-based (FASTPlaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum. Int J Tuberc Lung Dis. 2004;8:1114-1119. (Pubitemid 39201258)
20. Murray SJ, Barrett A, Magee JG, Freeman R. Optimisation of acid fast smears for the direct detection of mycobacteria in clinical samples. J Clin Pathol. 2003;56:613-615. (Pubitemid 36976361)
21. Chakravorty S, Dudeja M, Hanif M, Tyagi JS. Utility of universal sample processing methodology, combining smear microscopy, culture, and PCR, for diagnosis of pulmonary tuberculosis. J Clin Microbiol. 2005;43:2703-2708. (Pubitemid 40827942)
22. Van Klingeren B, Dessens-Kroon M, van der Laan T, Kremer K, van Soolingen D. Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method. J Clin Microbiol. 2007;45:2662-2668. (Pubitemid 47295501)
23. Grandjean L, Martin L, Gilman RH, et al. Tuberculosis diagnosis and multidrug resistance testing by direct sputum culture in selective broth without decontamination or centrifugation. J Clin Microbiol. 2008;46:2339-2344.
24. Cattamanchi A, Davis JL, Worodria W, et al. Poor performance of universal sample processing method for diagnosis of pulmonary tuberculosis by smear microscopy and culture in Uganda. J Clin Microbiol. 2008;46:3325-3329.
25. Park MY, Kim YJ, Hwang SH, et al. Evaluation of an immunochromatographic assay kit for rapid identification of Mycobacterium tuberculosis complex in clinical isolates. J Clin Microbiol. 2009;47:481-484.
26. World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB): policy statement. http://www.who.int/tb/laboratory/lpa-policy.pdf. Published June 27, 2008. Accessed November 2011.
27. Rossau R, Traore H, De Beenhouwer H, et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother. 1997;41:2093-2098. (Pubitemid 27422196)
28. Traore H, Fissette K, Bastian I, Devleeschouwer M, Portaels F. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis. 2000;4:481-484. (Pubitemid 30256852)
29. Viveiros M, Leandro C, Rodrigues L, et al. Direct application of the INNOLiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smearpositive respiratory specimens from an area of high incidence of multidrugresistant tuberculosis. J Clin Microbiol. 2005;43:4880-4884. (Pubitemid 41298302)
30. Quezada CM, Kamanzi E, Mukamutara J, et al. Implementation validation performed in Rwanda to determine whether the INNO-LiPa Rif.TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries. J Clin Microbiol. 2007;45:3111-3114. (Pubitemid 47417369)
31. Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2005;5:62.
32. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. Use of Genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol. 2006;44:2485-2491. (Pubitemid 44092416)
33. Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfinger M. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J Clin Microbiol. 2006;44:4459-4463. (Pubitemid 44940754)
34. Bang D, Andersen A° B, Thomsen VO. Rapid genotypic detection of rifampin-and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J Clin Microbiol. 2006;44:2605-2608. (Pubitemid 44092440)
35. Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol. 2007;45:2635-2640. (Pubitemid 47295497)
36. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008;177:787-792. (Pubitemid 351490566)
37. Vijdea R, Stegger M, Sosnovskaja A, Andersen AB, Thomsen VO, Bang D. Multi-drug resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolates. Eur J Clin Microbiol Infect Dis. 2008;27:1079-1086.
38. Lacoma A, Garcia-Sierra N, Prat C, et al. GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol. 2008;46:3660-3667.
39. Akpaka PE, Baboolal S, Clarke D, Francis L, Rastogi N. Evaluation of methods for rapid detection of resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates collected in the Caribbean. J Clin Microbiol. 2008;46:3426-3428.
40. Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug resistant tuberculosis: a meta-analysis. Eur Respir J. 2008;32:1165-1174.
41. Bwanga F, Hoffner S, Haile M, Joloba ML. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis. 2009;9:67.
42. Cauwelaert ND, Ramarokoto H, Ravololonandriana P, Richard V, Rasolofo V. DNA extracted from stained sputum smears can be used in the MTBDRplus assay. J Clin Microbiol. 2011;49:3600-3603.
43. Hillemann D, Rusch-Gerdes S, Richter E. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol. 2009;47:1767-1772.
44. Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J Clin Microbiol. 2010;48:1683-1689.
45. Huang W-L, Chi T-L, Wu M-H, Jou R. Performance assessment of the GenoType MTBDRsl test and DNA Sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2011;49:2502-2508.
46. Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol. 2010;48:2495-2501.
47. Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of an on-demand, near-patient technology. J Clin Microbiol. 2010;48:229-237.
48. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363;1005-1015.
49. Armand S, Vanhuls P, Delcroix G, Courcol R, Lemaitre N. Comparison of the Xpert MTB/RIB test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol. 2011;49:1772-1776.
50. Teo J, Jureen R, Chiang D, Chan D, Lin R. Comparison of two nucleic acid amplification assays, the Xpert MTB/RIF assay and the Amplified Mycobacterium Tuberculosis Direct assay, for detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol. 2011;49:3659-3662.
51. Theron G, Peter J, van Zyl-Smit R, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting [published online ahead of print April 14, 2011]. Am J Respir Crit Care Med. 2011;184(1):132-140.
52. Nicol MP, Workman L, Isaacs W, et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis. 2011;11:819-824.
53. Gotuzzo E. Xpert MTB/RIF for diagnosis of pulmonary tuberculosis. Lancet Infect Dis. 2011;11:802-803.
54. Neonakis IK, Spandidos DA, Petinaki E. Use of loop-mediated isothermal amplification of DNA for the rapid detection of Mycobacterium tuberculosis in clinical specimens. Eur J Clin Microbiol Infect Dis. 2011;30:937-942.
55. Iwamoto T, Sonobe T, Hayashi K. Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, M. avium, and M. intracellulare in sputum samples. J Clin Microbiol. 2003; 41;2616-2622. (Pubitemid 36712475)
56. Boehme CC, Nabeta P, Henostroza G, et al. Operational feasibility of using Loop-Mediated Isothermal Amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol. 2007;45:1936-1940. (Pubitemid 46933929)
57. Pandey BD, Poudel A, Yoda T, et al. Development of an in-house loopmediated isothermal amplification (LAMP) assay for detection of Mycobacterium tuberculosis and evaluation of sputum samples of Nepalese patients. J Med Microbiol. 2008;57:439-443. (Pubitemid 351537017)
58. Zhu RY, Zhang KX, Zhao MQ, et al. Use of the visual loop-mediated isothermal amplification of rimM sequence for rapid detection of Mycobacterium tuberculosis and Mycobacterium bovis. J Microbiol Methods. 2009;78:339-343.
59. Lee MF, Chen YH, Peng CF. Evaluation of reverse transcription loopmediated isothermal amplification in conjunction with ELISA-hybridization assay for molecular detection of Mycobacterium tuberculosis. J Microbiol Methods. 2009;76:174-180.
60. Aryan E, Makvandi M, Farajzadeh A, et al. A novel and more sensitive loop-mediated isothermal amplification assay targeting IS6110 for detection of Mycobacterium tuberculosis complex. Microbiol Res. 2010;165:211-220.
61. Caoili JC, Mayorova A, Sikes D, Hickman L, Plikaytis BB, Shinnick TM. Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol. 2006;44:2378-2381. (Pubitemid 44092401)
62. Wilson ML. Recent advances in the laboratory detection of Mycobacterium tuberculosis complex and drug resistance. Clin Infect Dis. 2011;52:1350-1355.
63. Murray CK, Gasser RA, Magill AJ, Miller RS. Update on rapid diagnostic testing for malaria. Clin Microbiol Rev. 2008;21:97-110. (Pubitemid 351160011)
64. Yagui M, Perales MT, Asencios L, et al. Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient? Int J Tuberc Lung Dis. 2006;10:838-843. (Pubitemid 44197842)
65. O'Donnel MR, Zelnick J, Werner L, et al. Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South Africa. Emerg Infect Dis. 2011;17:1942-1945.